NAMSA, a biotech company, completed the acquisition of Perfectus Biomed Group, a standard and customized microbiology testing services company. Financial terms were not disclosed. “NAMSA very much looks forward to expanding its European suite of laboratory services with the addition of Perfectus Biomed Group. Perfectus brings an unmatched level of expertise and depth of knowledge in customized microbiological testing solutions. This know-how and extreme proficiency in microbiological research will help us further support Clients and continue to provide cutting-edge solutions for medical device testing and research,” Christophe Berthoux, NAMSA CEO.